- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Agfa buys stake in RIS firm
Agfa Healthcare has expanded its RIS portfolio with the purchase of a minority stake in Med2Rad, an Italian medical software company. Med2Rad developed the Elefante RIS, currently installed in more than 75 Italian hospitals. The Belgian company has for
Agfa Healthcare has expanded its RIS portfolio with the purchase of a minority stake in Med2Rad, an Italian medical software company. Med2Rad developed the Elefante RIS, currently installed in more than 75 Italian hospitals. The Belgian company has for several years been the exclusive marketer and vendor for Elefante in the Italian market, as part of an integrated RIS/PACS and as a stand-alone RIS. Agfa made the investment to allow greater integration between its Impax and Med2Rad's Elefante, leading eventually to a common IT platform, according to the firm.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
